This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of entacapone
PDMED_ENTACAPONE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
271 |
4. Check minimum number of events
Min. number of events
3
|
271 |
5. Include endpointsNone |
271 |
6. Filter based on genotype QC (FinnGen only) |
262 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Similar endpoints
↥List of similar endpoints to
Use of entacapone
based on the number of shared cases.
Similar with more cases:
- Use of levodopa decarboxylase inhibitor
- Parkinson's disease
- Parkinson's disease
- Parkinson's disease, including avohilmo
- Extrapyramidal and movement disorders
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 262 | 92 | 170 |
| Unadjusted period prevalence (%) | 0.07 | 0.04 | 0.09 |
| Median age at first event (years) | 69.00 | 66.96 | 70.11 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_ENTACAPONE – Use of entacapone
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).